Drug Shortage Report for MS.IR
Report ID | 145961 |
Drug Identification Number | 02014238 |
Brand name | MS.IR |
Common or Proper name | Morphine Sulfate Immediate Release Tablets |
Company Name | PURDUE PHARMA |
Market Status | MARKETED |
Active Ingredient(s) | MORPHINE SULFATE |
Strength(s) | 20MG |
Dosage form(s) | TABLET (IMMEDIATE RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 60 |
ATC code | N02AA |
ATC description | OPIOIDS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2021-09-21 |
Actual start date | 2021-09-21 |
Estimated end date | 2021-12-24 |
Actual end date | 2021-12-17 |
Shortage status | Resolved |
Updated date | 2021-12-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-10-21 | English | Compare |
v3 | 2021-09-22 | English | Compare |
v2 | 2021-09-21 | French | Compare |
v1 | 2021-09-21 | English | Compare |